Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist.
Marion Hemmersbach-MillerRobert P WoodCameron R WolfePublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2020)
A 61-year-old female with well-controlled human immunodeficiency virus (HIV) and end-stage renal disease was on the kidney transplant waitlist awaiting an organ offer, including from HIV-positive donors through the HIV Organ Policy Equity (HOPE) Act. We present three different scenarios where HIV-positive donor offers were evaluated for this one recipient, discuss the donor evaluation process, explain where the infectious diseases provider fits in this scheme, and describe the challenges encountered by organ procurement organizations. This is the first case under the HOPE Act at our center where discovery of an HIV-specific issue led to a turndown of an organ offer.
Keyphrases
- hiv positive
- antiretroviral therapy
- human immunodeficiency virus
- infectious diseases
- men who have sex with men
- hiv infected
- south africa
- hiv testing
- hiv aids
- end stage renal disease
- hepatitis c virus
- chronic kidney disease
- peritoneal dialysis
- healthcare
- small molecule
- mental health
- high throughput
- palliative care
- mesenchymal stem cells
- bone marrow
- cell therapy
- global health